[HTML][HTML] Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease

YG Yang, T Lindahl, DE Barnes - Cell, 2007 - cell.com
YG Yang, T Lindahl, DE Barnes
Cell, 2007cell.com
Trex1 is the major 3′ DNA exonuclease in mammalian cells, and mutations in the human
TREX1 gene can cause Aicardi-Goutières syndrome, characterized by perturbed immunity.
Similarly, Trex1−/− mice have an autoinflammatory phenotype; however, the mechanism of
Trex1-deficient disease is unknown. We report that Trex1, ordinarily associated with the
endoplasmic reticulum (ER), relocalizes to the S phase nucleus after γ irradiation or
hydroxyurea treatment. Notably, Trex1-deficient cells show defective G1/S transition and …
Summary
Trex1 is the major 3′ DNA exonuclease in mammalian cells, and mutations in the human TREX1 gene can cause Aicardi-Goutières syndrome, characterized by perturbed immunity. Similarly, Trex1−/− mice have an autoinflammatory phenotype; however, the mechanism of Trex1-deficient disease is unknown. We report that Trex1, ordinarily associated with the endoplasmic reticulum (ER), relocalizes to the S phase nucleus after γ irradiation or hydroxyurea treatment. Notably, Trex1-deficient cells show defective G1/S transition and chronic ATM-dependent checkpoint activation, even in the absence of exogenous stress, correlating with persistent single-stranded DNA molecules produced in S phase, which accumulate in the ER. Our data indicate that Trex1 acts on a single-stranded DNA polynucleotide species generated from processing of aberrant replication intermediates to attenuate DNA damage checkpoint signaling and prevent pathological immune activation.
cell.com